Bertrand Hermann , Sarah Benghanem , Estelle Pruvost-Robieux , Tarek Sharshar , Martine Gavaret , Alain Cariou , Jean-Luc Diehl , Diego Candia-Rivera
{"title":"Brain-heart interactions are associated with mortality and acute encephalopathy in ICU patients with severe COVID-19","authors":"Bertrand Hermann , Sarah Benghanem , Estelle Pruvost-Robieux , Tarek Sharshar , Martine Gavaret , Alain Cariou , Jean-Luc Diehl , Diego Candia-Rivera","doi":"10.1016/j.clinph.2025.2110745","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Research in critical care has revealed the significance of autonomic dysfunctions, and more recently of brain–heart interactions, as valuable biomarkers for evaluating patients’ physiological status. These biomarkers provide insights into consciousness levels, severity, and outcomes. This study aims to determine the potential of these biomarkers in predicting the mortality and neurological outcome of severe COVID-19 patients.</div></div><div><h3>Methods</h3><div>We examined severe COVID-19 patients who required mechanical ventilation and observed them both during sedation and after sedation cessation. Standard EEG and ECG recordings were conducted at bedside, from which 5 min of continuous data were analyzed. Using a synthetic data generation model, we evaluated bidirectional brain–heart interactions from EEG power and heartbeat dynamics series.</div></div><div><h3>Results</h3><div>Our findings indicate that brain–heart interactions, especially involving cardiac parasympathetic activity, indicate the degree of patients’ severity. We observed correlations with acute encephalopathy duration (coma and delirium), particularly evident in top-down markers (from brain to heart) while bottom-up signaling (from heart to brain) correlated with ICU mortality. Additionally, we noted stronger modulation of brain–heart interactions in milder patients when comparing sedation versus non-sedation conditions, compared to those in more severe states.</div></div><div><h3>Conclusions</h3><div>Our results imply that autonomic dysfunctions, as measured through brain–heart interactions, can track the pathophysiology of comatose states following SARS-CoV-2 infection.</div></div><div><h3>Significance</h3><div>These findings highlight the potential of brain–heart interactions as an integrated marker for autonomic function in critical care, offering a more accurate assessment of patient severity and outcomes compared to isolated cardiac or brain measures.</div></div>","PeriodicalId":10671,"journal":{"name":"Clinical Neurophysiology","volume":"175 ","pages":"Article 2110745"},"PeriodicalIF":3.7000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurophysiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1388245725005978","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Research in critical care has revealed the significance of autonomic dysfunctions, and more recently of brain–heart interactions, as valuable biomarkers for evaluating patients’ physiological status. These biomarkers provide insights into consciousness levels, severity, and outcomes. This study aims to determine the potential of these biomarkers in predicting the mortality and neurological outcome of severe COVID-19 patients.
Methods
We examined severe COVID-19 patients who required mechanical ventilation and observed them both during sedation and after sedation cessation. Standard EEG and ECG recordings were conducted at bedside, from which 5 min of continuous data were analyzed. Using a synthetic data generation model, we evaluated bidirectional brain–heart interactions from EEG power and heartbeat dynamics series.
Results
Our findings indicate that brain–heart interactions, especially involving cardiac parasympathetic activity, indicate the degree of patients’ severity. We observed correlations with acute encephalopathy duration (coma and delirium), particularly evident in top-down markers (from brain to heart) while bottom-up signaling (from heart to brain) correlated with ICU mortality. Additionally, we noted stronger modulation of brain–heart interactions in milder patients when comparing sedation versus non-sedation conditions, compared to those in more severe states.
Conclusions
Our results imply that autonomic dysfunctions, as measured through brain–heart interactions, can track the pathophysiology of comatose states following SARS-CoV-2 infection.
Significance
These findings highlight the potential of brain–heart interactions as an integrated marker for autonomic function in critical care, offering a more accurate assessment of patient severity and outcomes compared to isolated cardiac or brain measures.
期刊介绍:
As of January 1999, The journal Electroencephalography and Clinical Neurophysiology, and its two sections Electromyography and Motor Control and Evoked Potentials have amalgamated to become this journal - Clinical Neurophysiology.
Clinical Neurophysiology is the official journal of the International Federation of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, the Italian Clinical Neurophysiology Society and the International Society of Intraoperative Neurophysiology.The journal is dedicated to fostering research and disseminating information on all aspects of both normal and abnormal functioning of the nervous system. The key aim of the publication is to disseminate scholarly reports on the pathophysiology underlying diseases of the central and peripheral nervous system of human patients. Clinical trials that use neurophysiological measures to document change are encouraged, as are manuscripts reporting data on integrated neuroimaging of central nervous function including, but not limited to, functional MRI, MEG, EEG, PET and other neuroimaging modalities.